Medicinal product name | Linefor 75 mg hard capsules |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Capsule, hard | ||||||
Strength | 75 mg | ||||||
Information from the MAH on shortages | No information on expected shortages | ||||||
Availability of medicinal product |
|
||||||
Legal status | Prescription (Pr.III) | ||||||
Package leaflet | 11-08-2022 | ||||||
Summary of product characteristics | 11-08-2022 | ||||||
ATC code | N02BF02 – Analgesics |
Medicinal products (6)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (75 mg) |
PVC/PVDC/Al blister | 17-0124-01 |
Labelling text Dec 8, 2020 |
|
Is available (according to the information provided by wholesalers) (534 containers) |
Tamro, Magnum Medical, Baltfarm "Vita-Farm" |
N56 (75 mg) |
PVC/PVDC/Al blister | € 14.56 | 17-0124-02 |
Labelling text Dec 8, 2020 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (75 mg) |
PVC/PVDC/Al blister | 17-0124-03 |
Labelling text Dec 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N84 (75 mg) |
PVC/PVDC/Al blister | 17-0124-04 |
Labelling text Dec 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N21 (75 mg) |
PVC/PVDC/Al blister | 17-0124-05 |
Labelling text Dec 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (75 mg) |
PVC/PVDC/Al blister | 17-0124-06 |
Labelling text Dec 8, 2020 |
Registration information
Marketing authorisation No. | 17-0124 |
---|---|
Date of authorisation | Jun 12, 2017 |
Marketing authorisation holder, country | Zaklady Farmaceutyczne Polpharma S.A., Poland |